Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Proassurance (PRA) Current Deferred Revenue (2016 - 2026)

Proassurance has reported Current Deferred Revenue over the past 17 years, most recently at $403.9 million for Q4 2025.

  • Quarterly Current Deferred Revenue fell 3.55% to $403.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $403.9 million through Dec 2025, down 3.55% year-over-year, with the annual reading at $403.9 million for FY2025, 3.55% down from the prior year.
  • Current Deferred Revenue was $403.9 million for Q4 2025 at Proassurance, down from $458.4 million in the prior quarter.
  • Over five years, Current Deferred Revenue peaked at $509.3 million in Q3 2021 and troughed at $375.2 million in Q1 2021.
  • The 5-year median for Current Deferred Revenue is $454.5 million (2022), against an average of $452.8 million.
  • Year-over-year, Current Deferred Revenue dropped 15.35% in 2021 and then grew 29.7% in 2022.
  • A 5-year view of Current Deferred Revenue shows it stood at $434.0 million in 2021, then decreased by 2.54% to $423.0 million in 2022, then increased by 2.55% to $433.7 million in 2023, then decreased by 3.45% to $418.8 million in 2024, then dropped by 3.55% to $403.9 million in 2025.
  • Per Business Quant, the three most recent readings for PRA's Current Deferred Revenue are $403.9 million (Q4 2025), $458.4 million (Q3 2025), and $425.6 million (Q2 2025).